Silverarc Capital Management, LLC Portfolio Holdings
Silverarc Capital Management, LLC
- $298 Million
- Q1 2024
Silverarc Capital Management, LLC has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $298 Million distributed in 77 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $25.5M, Morphic Holding, Inc. with a value of $17M, Oric Pharmaceuticals, Inc. with a value of $15.3M, Mersana Therapeutics, Inc. with a value of $13.3M, and Celldex Therapeutics, Inc. with a value of $12.6M.
Examining the 13F form we can see an decrease of $18.5M in the current position value, from $316M to 298M.
Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.